Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Non-receptor tyrosine kinase signaling in autoimmunity and therapeutic implications
Sabrina Solouki, Avery August, Weishan Huang
Pharmacology & Therapeutics (2019) Vol. 201, pp. 39-50
Open Access | Times Cited: 23

Showing 23 citing articles:

Protein tyrosine kinase inhibitor resistance in malignant tumors: molecular mechanisms and future perspective
Yang Yang, Shuo Li, Yujiao Wang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 141
Adaptive immune cells are necessary for SARS-CoV-2–induced pathology
Brian Imbiakha, Julie Sahler, David W. Buchholz, et al.
Science Advances (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 8
Janus kinases (JAKs): The efficient therapeutic targets for autoimmune diseases and myeloproliferative disorders
Pengfei Xu, Pei Shen, Bin Yu, et al.
European Journal of Medicinal Chemistry (2020) Vol. 192, pp. 112155-112155
Closed Access | Times Cited: 56
The Src-family Kinase Lyn in Immunoreceptor Signaling
Ben F. Brian, Tanya S. Freedman
Endocrinology (2021) Vol. 162, Iss. 10
Open Access | Times Cited: 52
BTK/ITK dual inhibitors: Modulating immunopathology and lymphopenia for COVID-19 therapy
Michael C. McGee, Avery August, Weishan Huang
Journal of Leukocyte Biology (2020) Vol. 109, Iss. 1, pp. 49-53
Open Access | Times Cited: 33
Targeted and untargeted metabolomics uncovering the effects of Jiawei Ermiao Granule on patients with persistent HPV infection
Xiu Li, Ning Li, Hongting Zhao, et al.
Frontiers in Cellular and Infection Microbiology (2025) Vol. 15
Open Access
COVID-19 and pulmonary fibrosis: therapeutics in clinical trials, repurposing, and potential development
Joowon Yim, Hee Hyun Lim, Youngjoo Kwon
Archives of Pharmacal Research (2021) Vol. 44, Iss. 5, pp. 499-513
Open Access | Times Cited: 26
Non-Receptor Tyrosine Kinases: Their Structure and Mechanistic Role in Tumor Progression and Resistance
Abdulaziz M. Eshaq, Thomas W. Flanagan, Sofie-Yasmin Hassan, et al.
Cancers (2024) Vol. 16, Iss. 15, pp. 2754-2754
Open Access | Times Cited: 3
Overview of pyroptosis mechanism and in-depth analysis of cardiomyocyte pyroptosis mediated by NF-κB pathway in heart failure
Zeyu Zhang, Zhihua Yang, Shuai Wang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 179, pp. 117367-117367
Open Access | Times Cited: 3
Bruton Tyrosine Kinase Inhibition and Its Role as an Emerging Treatment in Pemphigus
Aikaterini Patsatsi, Dédée F. Murrell
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 18
Theoretical Studies of DNA Microarray Present Potential Molecular and Cellular Interconnectivity of Signaling Pathways in Immune System Dysregulation
Jon Patrick T. Garcia, Lemmuel L. Tayo
Genes (2024) Vol. 15, Iss. 4, pp. 393-393
Open Access | Times Cited: 2
Recent research of BTK inhibitors: Methods of structural design, pharmacological activities, manmade derivatives and structure–activity relationship
Lin Wang, Zhengjie Zhang, Dongke Yu, et al.
Bioorganic Chemistry (2023) Vol. 138, pp. 106577-106577
Closed Access | Times Cited: 6
Immunopharmacology and Quantitative Analysis of Tyrosine Kinase Signaling
Ben F. Brian, Candace R. Guerrero, Tanya S. Freedman
Current Protocols in Immunology (2020) Vol. 130, Iss. 1
Open Access | Times Cited: 13
Role of Tyrosine Kinases and their Inhibitors in Cancer Therapy: A Comprehensive Review
Vanktesh Kumar, Navjot Kaur, Sanjeev Kumar Sahu, et al.
Current Medicinal Chemistry (2022) Vol. 30, Iss. 13, pp. 1464-1481
Closed Access | Times Cited: 8
Development and validation of an inflammatory response-related prognostic model and immune infiltration analysis in glioblastoma
Wenjun Zhu, Na Luo, Qianxia Li, et al.
Annals of Translational Medicine (2023) Vol. 11, Iss. 2, pp. 69-69
Open Access | Times Cited: 4
Role of non-receptor tyrosine kinases in epilepsy: significance and potential as therapeutic targets
Ozasvi R Shanker, Sonali Kumar, Jyotirmoy Banerjee, et al.
Expert Opinion on Therapeutic Targets (2024) Vol. 28, Iss. 4, pp. 283-294
Closed Access | Times Cited: 1
Substrate-Mediated Regulation of Src Expression Drives Osteoclastogenesis Divergence
Bo Hu, Yi‐Ming Chen, Yuman Li, et al.
Genes (2024) Vol. 15, Iss. 9, pp. 1217-1217
Open Access | Times Cited: 1
Expression and Tumor-Promoting Effect of Tyrosine Phosphatase Receptor Type N (PTPRN) in Human Glioma
Dong Wang, Fan Tang, Xi Liu, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 9
Target Occupancy and Functional Inhibition of JAK3 and TEC Family Kinases by Ritlecitinib in Healthy Adults: An Open‐Label, Phase 1 Study
Roland Martinꝉ, Jean‐Baptiste Telliez, Susan Pleasic‐Williams, et al.
The Journal of Clinical Pharmacology (2023) Vol. 64, Iss. 1, pp. 67-79
Open Access | Times Cited: 3
Src-related thrombocytopenia: a fine line between a megakaryocyte dysfunction and an immune-mediated disease
Verónica Palma‐Barqueros, Nuria Revilla, Carlo Zaninetti, et al.
Blood Advances (2022) Vol. 6, Iss. 17, pp. 5244-5255
Open Access | Times Cited: 5
PATHOPHYSIOLOGY OF METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS AND DRUG RESISTANCE
Ataa Elias Karum, Soha Jassim Mohammed, Sanaa Adnan Abdul Hussein, et al.
Journal of Medical Genetics and Clinical Biology (2024) Vol. 1, Iss. 4, pp. 71-77
Open Access
Syk protein inhibitors treatment for the allergic symptoms associated with hyper immunoglobulin E syndromes: A focused on a computational approach
Mariam Mansouri, Ghyzlane ElHaddoumi, Ilham Kandoussi, et al.
International Journal of Immunopathology and Pharmacology (2024) Vol. 38
Open Access
Oxidative modifications control aberrant tyrosine kinase activity
Paul Schulan, Kristian Wende, Thomas von Woedtke, et al.
Biointerphases (2022) Vol. 19, Iss. 6
Closed Access
Page 1

Scroll to top